Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1950
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1959 1
1961 1
1962 2
1964 2
1965 2
1966 4
1968 1
1969 4
1970 3
1971 3
1972 1
1973 1
1974 1
1975 1
1980 3
1982 3
1983 1
1984 2
1985 3
1989 6
1990 3
1991 1
1992 3
1994 7
1995 4
1996 6
1997 2
1998 5
1999 6
2000 4
2001 6
2002 1
2003 6
2004 3
2005 4
2006 4
2007 5
2008 3
2009 2
2010 7
2011 4
2012 5
2013 6
2014 2
2015 3
2016 2
2017 4
2018 2
2019 4
2020 5
2021 4
2023 2
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

161 results

Results by year

Filters applied: . Clear all
Page 1
A target discovery pipeline identified ILT3 as a target for immunotherapy of multiple myeloma.
Di Meo F, Iyer A, Akama K, Cheng R, Yu C, Cesarano A, Kurihara N, Tenshin H, Aljoufi A, Marino S, Soni RK, Roda J, Sissons J, Vu LP, Guzman M, Huang K, Laskowski T, Broxmeyer HE, Roodman DG, Perna F. Di Meo F, et al. Among authors: akama k. Cell Rep Med. 2023 Jul 18;4(7):101110. doi: 10.1016/j.xcrm.2023.101110. Cell Rep Med. 2023. PMID: 37467717 Free PMC article.
161 results